National Pension Service Has $170.19 Million Stake in CME Group Inc. $CME

National Pension Service increased its stake in CME Group Inc. (NASDAQ:CME) by 4.4% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 770,671 shares of the financial services provider’s stock after acquiring an additional 32,769 shares during the quarter. National Pension Service’s holdings in CME Group were worth $170,187,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Northwestern Mutual Investment Management Company LLC grew its holdings in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares during the period. Rehmann Capital Advisory Group raised its holdings in shares of CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares during the period. Endowment Wealth Management Inc. raised its holdings in shares of CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the period. NBT Bank N A NY boosted its position in shares of CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after purchasing an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC boosted its position in shares of CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Down 0.2%

CME opened at $274.07 on Friday. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm has a market capitalization of $98.55 billion, a PE ratio of 23.25, a P/E/G ratio of 3.25 and a beta of 0.24. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company’s 50-day moving average is $262.78 and its 200 day moving average is $277.43.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.96 EPS. As a group, research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of research analyst reports. Raymond James Financial reaffirmed an “outperform” rating and issued a $320.00 target price on shares of CME Group in a research report on Thursday, July 2nd. Piper Sandler cut their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Morgan Stanley raised their price objective on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Finally, Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $286.00 to $270.00 in a research report on Wednesday, August 19th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $289.75.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: New Treasury clearing platform could expand revenue opportunities. CME Group plans to launch CME Securities Clearing on December 7, ahead of an SEC mandate requiring central clearing for certain U.S. Treasury transactions. The service is intended to provide additional clearing capacity, customer choice and capital efficiency, potentially allowing CME to capture new clearing volumes and strengthen its position in the Treasury market. CME Group to Launch CME Securities Clearing
• Positive Sentiment: Shareholder payout remains a support. CME’s approximately $467 million dividend payment, scheduled for September 25, reinforces the company’s strong cash-generation profile and may appeal to income-focused investors. CME Group’s $467 Million Dividend
• Neutral Sentiment: Planned management transition appears orderly. CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. Internal promotions can reduce succession risk, although investors may monitor execution during the transition. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Market volatility could support trading activity. Conflicting Federal Reserve and Treasury policy signals may increase interest-rate and bond-market volatility, which can lift demand for CME’s hedging products, but also add uncertainty around the economic outlook. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation remains an overhang. An amicus brief urged dismissal of CME’s lawsuit against the CFTC concerning Hyperliquid, highlighting continued uncertainty around the exchange’s regulatory disputes and digital-asset ambitions. Hyperliquid Policy Center Files Amicus Brief

Insider Activity

In related news, Director William Shepard bought 325 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.